CVCI in €365m pharma exit

The private equity arm of Citi Capital Advisors has agreed to sell specialty pharmaceutical company Sanitas to Valeant Pharmaceuticals.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.